0001193125-13-168698.txt : 20130424 0001193125-13-168698.hdr.sgml : 20130424 20130424062729 ACCESSION NUMBER: 0001193125-13-168698 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20130423 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20130424 DATE AS OF CHANGE: 20130424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OWENS & MINOR INC/VA/ CENTRAL INDEX KEY: 0000075252 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047] IRS NUMBER: 541701843 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-09810 FILM NUMBER: 13777692 BUSINESS ADDRESS: STREET 1: 9120 LOCKWOOD BLVD CITY: MECHANICSVILLE STATE: VA ZIP: 23116 BUSINESS PHONE: 8047237000 MAIL ADDRESS: STREET 1: 9120 LOCKWOOD BLVD CITY: MECHANICSVILLE STATE: VA ZIP: 23116 FORMER COMPANY: FORMER CONFORMED NAME: O&M HOLDING INC DATE OF NAME CHANGE: 19940504 FORMER COMPANY: FORMER CONFORMED NAME: OWENS & MINOR INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: OWENS MINOR & BODEKER INC DATE OF NAME CHANGE: 19811124 8-K 1 d524827d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 24, 2013 (April 23, 2013)

 

 

Owens & Minor, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Virginia   1-9810   54-1701843

(State or other jurisdiction

of incorporation

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

9120 Lockwood Blvd., Mechanicsville, Virginia   23116
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (804) 723-7000

Not applicable

(former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a- 12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02. Results of Operations and Financial Condition.

On April 23, 2013, Owens & Minor, Inc. (the “Company”) issued a press release regarding its financial results for the first quarter ended March 31, 2013. The Company is furnishing the press release attached hereto as Exhibit 99.1 pursuant to Item 2.02 of Form 8-K. In accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

 

  (c) Exhibits.

 

  99.1 Press Release issued by the Company on April 23, 2013 (furnished pursuant to Item 2.02).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

      OWENS & MINOR, INC.
Date: April 24, 2013     By:  

/s/ Grace R. den Hartog

      Name:   Grace R. den Hartog
      Title:   Senior Vice President, General Counsel and Corporate Secretary


Exhibit Index

 

Exhibit
No.

  

Description

99.1    Press Release issued by the Company on April 23, 2013 (furnished pursuant to Item 2.02).
EX-99.1 2 d524827dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

April 23, 2013

Owens & Minor Reports 1st Quarter 2013 Financial Results

Management to host conference call to discuss results on

Wednesday, April 24, 2013, at 8:30 a.m.

Richmond, Va. — BUSINESS WIRE — April 23, 2013 — Owens & Minor, Inc. (NYSE-OMI) today reported financial results for the first quarter ended March 31, 2013, including consolidated quarterly revenues of $2.28 billion, an increase of 2.6%, when compared to revenues of $2.22 billion in the first quarter of 2012. Movianto, a leading European healthcare logistics provider acquired by Owens & Minor on August 31, 2012, contributed $121.0 million to first quarter revenues.

For the first quarter of 2013, consolidated net income was $26.1 million, or $0.41 per diluted share, compared to $29.4 million, or $0.46 per diluted share, for the same period last year. For the quarter, adjusted consolidated net income (non-GAAP), which excludes pre-tax charges of $2.0 million for acquisition-related and exit & realignment activities, was $27.6 million, or $0.44 per diluted share, compared to $29.4 million, or $0.46 per diluted share, for the same period last year.

“In looking at our quarterly results, we see that Owens & Minor is adapting to a changing healthcare market and is investing in areas that will provide us with opportunities for the future,” said Craig R. Smith, president & chief executive officer of Owens & Minor. “We continue to invest in our Domestic business to ensure that we have the necessary flexibility to serve our customers in healthcare. Internationally, we are working intently to integrate Movianto, fill excess capacity in the network, and reduce the cost structure. As we work through the integration, we remain excited about the opportunities in Europe.”

Adjusted consolidated operating earnings (non-GAAP) for the first quarter of 2013 were $49.9 million, or 2.19% of revenues, decreased $2.0 million, when compared to operating earnings of $51.9 million, or 2.34% of revenues, in the same period of 2012. The quarterly decline in consolidated operating earnings resulted primarily from an International segment operating loss of $3.0 million in the first quarter of 2013. For purposes of comparison, the first quarter 2012 results did not contain results from the company’s international operations.

 

1


Segment Results

Domestic segment revenues for the first quarter of 2013 were $2.15 billion, a decline of 2.8% when compared to the prior year’s first quarter revenue of $2.22 billion. On a per-sales-day basis, quarterly revenue declined by 1.3%. When compared to the prior year, the decline in first quarter Domestic segment revenues was partially due to rationalization of smaller, less profitable healthcare provider customers and suppliers. First quarter Domestic revenues were also affected by ongoing trends, including lower hospital utilization and reduced government purchases.

For the first quarter of 2013, Domestic segment operating earnings were $52.9 million, or 2.46% of revenues, an increase of $1.0 million, when compared to operating earnings of $51.9 million, or 2.34% of revenues, in the same period of 2012. Domestic segment operating earnings benefitted from supplier price changes, partially offset by an increase in workers’ compensation and consulting expenses.

The International segment contributed revenue of $121.0 million for the first quarter of 2013 and had a pre-tax operating loss of $3.0 million, which reduced consolidated net income per diluted share by $0.04. The quarterly operating loss resulted primarily from operating costs to support underutilized capacity.

Asset Management

The balance of cash and cash equivalents was $219 million at March 31, 2013, increased by $121 million from $98 million at December 31, 2012. For the first quarter of 2013, the company reported cash provided by operating activities of approximately $155 million compared to $102 million for the same period last year; results included a $98.2 million increase in accounts payable. Asset management metrics were strong with Domestic segment days sales outstanding (DSO) of 19.6 days as of March 31, 2013, compared to DSO of 19.9 days as of March 31, 2012. Domestic segment inventory turns were 10.6 for the first quarter of 2013, compared to inventory turns of 10.5 for the same period last year.

2013 Outlook

The company reaffirmed its financial guidance for 2013, which remains unchanged since it was provided at the company’s November 2012 Investor Day.

For 2013, the company is targeting revenue growth of 2% to 4% and adjusted net income per diluted share of $1.90 to $2.00 for the year, which includes operating results from the Movianto acquisition, but excludes exit and realignment costs, as well as acquisition-related costs.

The 2013 outlook is based on certain assumptions that are subject to the risk factors discussed in the company’s filings with the Securities & Exchange Commission.

 

2


Upcoming Investor Events

 

   

The company will hold its Annual Shareholders Meeting on Friday, April 26, 2013, at its Home Office in Mechanicsville, Va., at 10:00 a.m. EDT. Event audio and presentations will be archived on www.owens-minor.com following the conclusion of the meeting.

 

   

Owens & Minor is scheduled to participate in a number of investor conferences in the second quarter of 2013; webcasts of the company’s presentations at the following investor events will be posted on the company’s corporate website:

 

   

Bank of America Merrill Lynch 2013 Healthcare Conference; May 15 – Las Vegas

 

   

2013 UBS Global Healthcare Conference; May 21 – New York

 

   

Jefferies 2013 Global Healthcare Conference; June 6 – New York

 

   

34th Annual Goldman Sachs Global Healthcare Conference; June 12 – Rancho Palos Verdes

Investors Conference Call & Supplemental Material

Conference Call: Owens & Minor will conduct a conference call for investors on Wednesday, April 24, 2013, at 8:30 a.m. EDT. The access code for the conference call, international dial-in and replay is #35997867. Participants may access the call at 866-393-1604. The international dial-in number is 224-357-2191. Replay: A replay of the call will be available for one week by dialing 855-859-2056. Webcast: A listen-only webcast of the call, along with supplemental information, will be available on www.owens-minor.com under “Investor Relations.”

Information on www.Owens-Minor.com

Owens & Minor uses its website as a channel of distribution for material company information, including news releases, investor presentations and financial information. This information is routinely posted and accessible under Investor Relations at www.owens-minor.com.

Safe Harbor Statement

Except for historical information, the matters discussed in this press release may constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risk factors are discussed in reports filed by the company with the Securities & Exchange Commission. All of this information is available at www.owens-minor.com. The company assumes no obligation, and expressly disclaims any such obligation, to update or alter information, whether as a result of new information, future events, or otherwise.

Owens & Minor, Inc., (NYSE: OMI) a FORTUNE 500 company headquartered in Richmond, Virginia, is a leading national distributor of name-brand medical and surgical supplies. Owens & Minor also offers global third-party logistics services to pharmaceutical, life-science, and medical-device manufacturers through its European business unit, Movianto, and through its U.S.-based service, OM HealthCare Logistics. With a diverse product and service offering and distribution centers throughout the United States, the company serves hospitals, integrated healthcare systems, alternate site locations, group purchasing organizations, healthcare manufacturers, and the federal government. Owens & Minor also provides technology and

 

3


consulting programs that improve inventory management and streamline logistics across the entire medical supply chain. For news releases, or for more information about Owens & Minor, visit the company website at www.owens-minor.com.

CONTACTS:

Truitt Allcott, Director, Investor & Media Relations, 804-723-7555, truitt.allcott@owens-minor.com

Chuck Graves, Director, Finance & Investor Relations, 804-723-7556, chuck.graves@owens-minor.com

# # # #

 

4


Page 5

 

Owens & Minor, Inc.

Consolidated Statements of Income (unaudited)

(in thousands, except per share data)

 

     Three Months Ended March 31,  
     2013     2012  

Net revenue

   $ 2,275,709      $ 2,217,882   

Cost of goods sold

     1,996,657        2,003,554   
  

 

 

   

 

 

 

Gross margin

     279,052        214,328   

Selling, general and administrative expenses

     217,721        155,572   

Acquisition-related and exit and realignment charges

     2,010        —      

Depreciation and amortization

     12,629        8,578   

Other operating income, net

     (1,192     (1,694
  

 

 

   

 

 

 

Operating earnings

     47,884        51,872   

Interest expense, net

     3,199        3,422   
  

 

 

   

 

 

 

Income before income taxes

     44,685        48,450   

Income tax provision

     18,587        19,090   
  

 

 

   

 

 

 

Net income

   $ 26,098      $ 29,360   
  

 

 

   

 

 

 

Net income per common share:

    

Basic

   $ 0.41      $ 0.46   

Diluted

   $ 0.41      $ 0.46   


Page 6

 

Owens & Minor, Inc.

Condensed Consolidated Balance Sheets (unaudited)

(in thousands)

 

     March 31,
2013
     December 31,
2012
 

Assets

     

Current assets

     

Cash and cash equivalents

   $ 218,563       $ 97,888   

Accounts and notes receivable, net

     581,121         553,502   

Merchandise inventories

     743,247         763,756   

Other current assets

     205,342         213,748   
  

 

 

    

 

 

 

Total current assets

     1,748,273         1,628,894   

Property and equipment, net

     187,927         191,841   

Goodwill, net

     272,878         274,884   

Intangible assets, net

     39,645         42,313   

Other assets, net

     72,199         69,769   
  

 

 

    

 

 

 

Total assets

   $ 2,320,922       $ 2,207,701   
  

 

 

    

 

 

 

Liabilities and equity

     

Current liabilities

     

Accounts payable

   $ 693,616       $ 603,137   

Accrued payroll and related liabilities

     18,823         25,468   

Deferred income taxes

     41,455         40,758   

Other current liabilities

     282,974         254,924   
  

 

 

    

 

 

 

Total current liabilities

     1,036,868         924,287   

Long-term debt, excluding current portion

     214,243         215,383   

Deferred income taxes

     28,639         30,921   

Other liabilities

     63,622         63,454   
  

 

 

    

 

 

 

Total liabilities

     1,343,372         1,234,045   

Total equity

     977,550         973,656   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 2,320,922       $ 2,207,701   
  

 

 

    

 

 

 


Page 7

 

Owens & Minor, Inc.

Consolidated Statements of Cash Flows (unaudited)

(in thousands)

 

     Three Months Ended March 31,  
     2013     2012  

Operating activities:

    

Net income

   $ 26,098      $ 29,360   

Adjustments to reconcile net income to cash provided by operating activities of continuing operations:

    

Depreciation and amortization

     12,629        8,578   

Share-based compensation expense

     1,910        2,385   

Provision for losses on accounts and notes receivable

     107        190   

Deferred income tax benefit

     (56     (1,465

Changes in operating assets and liabilities:

    

Accounts and notes receivable

     (34,575     7,553   

Merchandise inventories

     21,784        82,160   

Accounts payable

     98,198        (38,279

Net change in other assets and liabilities

     28,981        11,609   

Other, net

     (465     (194
  

 

 

   

 

 

 

Cash provided by operating activities of continuing operations

     154,611        101,897   
  

 

 

   

 

 

 

Investing activities:

    

Additions to property and equipment

     (7,513     (4,536

Additions to computer software and intangible assets

     (7,264     (3,840

Proceeds from the sale of property and equipment

     44        99   
  

 

 

   

 

 

 

Cash used for investing activities of continuing operations

     (14,733     (8,277
  

 

 

   

 

 

 

Financing activities:

    

Cash dividends paid

     (15,199     (14,001

Repurchases of common stock

     (2,282     (3,750

Excess tax benefits related to share-based compensation

     207        690   

Proceeds from exercise of stock options

     1,792        3,371   

Other, net

     (1,958     (1,941
  

 

 

   

 

 

 

Cash used for financing activities of continuing operations

     (17,440     (15,631
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (1,763     —     
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

     120,675        77,989   

Cash and cash equivalents at beginning of period

     97,888        135,938   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 218,563      $ 213,927   
  

 

 

   

 

 

 


Page 8

 

Owens & Minor, Inc.

Financial Statistics and GAAP/Non-GAAP Reconciliations (unaudited)

 

     Quarter Ended  

(in thousands, except ratios and per share data)

   3/31/2013     12/31/2012     9/30/2012     6/30/2012     3/31/2012  

Consolidated operating results:

          

Net revenue

   $ 2,275,709      $ 2,324,924      $ 2,179,895      $ 2,185,444      $ 2,217,882   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

   $ 279,052      $ 270,774      $ 228,123      $ 211,429      $ 214,328   

Gross margin as a percent of revenue

     12.26     11.65     10.46     9.67     9.66
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

SG&A expenses

   $ 217,721      $ 211,415      $ 165,320      $ 150,288      $ 155,572   

SG&A expenses as a percent of revenue

     9.57     9.09     7.58     6.88     7.01
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating earnings, as reported (GAAP)

   $ 47,884      $ 45,041      $ 46,663      $ 53,177      $ 51,872   

Acquisition-related and exit and realignment charges

     2,010        1,717        7,831        617        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating earnings, adjusted (Non-GAAP)

   $ 49,894      $ 46,758      $ 54,494      $ 53,794      $ 51,872   

Operating earnings as a percent of revenue, adjusted (Non-GAAP)

     2.19     2.01     2.50     2.46     2.34
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income, as reported (GAAP)

   $ 26,098      $ 24,934      $ 24,597      $ 30,113      $ 29,360   

Acquisition-related and exit and realignment charges, after-tax

     1,521        1,237        6,588        375        —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income, adjusted (Non-GAAP)

   $ 27,619      $ 26,171      $ 31,185      $ 30,488      $ 29,360   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per diluted common share, as reported (GAAP)

   $ 0.41      $ 0.39      $ 0.39      $ 0.48      $ 0.46   

Acquisition-related and exit and realignment charges

     0.03        0.02        0.10        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per diluted common share, adjusted (Non-GAAP)

   $ 0.44      $ 0.41      $ 0.49      $ 0.48      $ 0.46   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Financing:

          

Cash and cash equivalents

   $ 218,563      $ 97,888      $ 79,667      $ 224,937      $ 213,927   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total interest-bearing debt

   $ 216,414      $ 217,591      $ 216,924      $ 213,982      $ 214,184   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Stock information:

          

Cash dividends per common share

   $ 0.24      $ 0.22      $ 0.22      $ 0.22      $ 0.22   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Stock price at quarter-end

   $ 32.56      $ 28.51      $ 29.88      $ 30.63      $ 30.41   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Use of Non-GAAP Measures

This earnings release contains financial measures that are not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). In general, the measures exclude items and charges that (i) management does not believe reflect Owens & Minor, Inc.‘s (the “Company”) core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred over multiple or in prior periods without predictable trends. Management uses these non-GAAP financial measures internally to evaluate the Company’s performance, evaluate the balance sheet, engage in financial and operational planning and determine incentive compensation.

Management provides these non-GAAP financial measures to investors as supplemental metrics to assist readers in assessing the effects of items and events on its financial and operating results and in comparing the Company’s performance to that of its competitors. However, the non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies.

The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements set forth above should be carefully evaluated.


Page 9

 

Owens & Minor, Inc.

Summary Segment Information (unaudited)

(in thousands, except ratios)

 

     Three Months Ended March 31,  
     2013     2012  
     Amount     % of
consolidated
net revenue
    Amount      % of
consolidated
net revenue
 

Net revenue:

         

Domestic

   $ 2,154,715        94.68   $ 2,217,882         100.00

International

     120,994        5.32        N/A         N/A   
  

 

 

   

 

 

   

 

 

    

 

 

 

Consolidated net revenue

   $ 2,275,709        100.00   $ 2,217,882         100.00
  

 

 

   

 

 

   

 

 

    

 

 

 
           % of segment
net revenue
           % of segment
net revenue
 

Operating earnings (loss):

         

Domestic

   $ 52,907        2.46   $ 51,872         2.34

International

     (3,013     (2.49 )%      N/A         N/A   

Acquisition-related and exit and realignment charges

     (2,010     N/A        —           N/A   
  

 

 

     

 

 

    

Consolidated operating earnings

   $ 47,884        2.10   $ 51,872         2.34
  

 

 

   

 

 

   

 

 

    

 

 

 

Depreciation and amortization:

         

Domestic

   $ 9,082        $ 8,578      

International

     3,547          N/A      
  

 

 

     

 

 

    

Consolidated depreciation and amortization

   $ 12,629        $ 8,578      
  

 

 

     

 

 

    

Capital expenditures: (1)

         

Domestic

   $ 11,602        $ 8,376      

International

     3,175          N/A      
  

 

 

     

 

 

    

Consolidated capital expenditures

   $ 14,777        $ 8,376      
  

 

 

     

 

 

    
     March 31,
2013
          December 31,
2012
        

Total assets:

         

Domestic

   $ 1,706,767        $ 1,723,699      

International

     395,592          386,114      
  

 

 

     

 

 

    

Segment assets

     2,102,359          2,109,813      

Cash and cash equivalents

     218,563          97,888      
  

 

 

     

 

 

    
   $ 2,320,922        $ 2,207,701      
  

 

 

     

 

 

    

 

(1) 

Represents additions to property and equipment and additions to computer software and separately acquired intangible assets.


Page 10

 

Owens & Minor, Inc.

Net Income Per Common Share (unaudited)

(in thousands, except per share data)

 

     Three Months Ended March 31,  
     2013     2012  

Numerator:

    

Net income

   $ 26,098      $ 29,360   

Less: income allocated to unvested restricted shares

     (195     (234
  

 

 

   

 

 

 

Net income attributable to common shareholders - basic

     25,903        29,126   

Add: undistributed income attributable to unvested restricted shares - basic

     58        96   

Less: undistributed income attributable to unvested restricted shares - diluted

     (58     (96
  

 

 

   

 

 

 

Net income attributable to common shareholders - diluted

   $ 25,903      $ 29,126   
  

 

 

   

 

 

 

Denominator:

    

Weighted average shares outstanding - basic

     62,687        62,802   

Dilutive shares - stock options

     58        99   
  

 

 

   

 

 

 

Weighted average shares outstanding - diluted

     62,745        62,901   
  

 

 

   

 

 

 

Net income per share attributable to common shareholders:

    

Basic

   $ 0.41      $ 0.46   

Diluted

   $ 0.41      $ 0.46